Other
α-Tocopherol
α-Tocopherol is an intervention with 3 clinical trials. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_2
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Not yet recruiting1
Completed1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (66.7%)
Phase 31 (33.3%)
Trials by Status
not_yet_recruiting133%
completed133%
terminated133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingphase_2
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
NCT06634056
completedphase_3
Impact of Oral Versatile Antioxidants on Glaucoma Progression
NCT01544192
terminatedphase_2
The Use of Pentoxifylline and Vitamin E in the Treatment of Late Radiation Related Injuries
NCT00188552
Clinical Trials (3)
Showing 3 of 3 trials
NCT06634056Phase 2
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
NCT01544192Phase 3
Impact of Oral Versatile Antioxidants on Glaucoma Progression
NCT00188552Phase 2
The Use of Pentoxifylline and Vitamin E in the Treatment of Late Radiation Related Injuries
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3